About the Company
We do not have any company description for Silexion Therapeutics Corp at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Silexion Therapeutics Corp
Silexion Therapeutics Corp trading halted, news pending
(Bloomberg) -- Samsung Electronics Co. shares climbed after it said it has struck a 22.8 trillion won ($16.5 billion) agreement to produce chips for an unidentified client, a potentially big win for ...
Silexion Therapeutics Corp. Reports 2024 Financial Results and ... - Nasdaq
Silexion Therapeutics Corp. announced its financial results for the fourth quarter and full year ended December 31, 2024, highlighting a transformative year marked by its Nasdaq listing and ...
Silexion Therapeutics Corp. Reports Positive Preclinical Data for ...
Silexion Therapeutics Corp. announced promising preclinical data for its RNA interference therapy, SIL204, which has shown significant efficacy against human lung cancer cell lines with KRAS G12D ...
Silexion Therapeutics Corp: Silexion Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company developing RNA interference ...
SLXN - Silexion Therapeutics Corp Valuation | Morningstar
Review the current valuation for Silexion Therapeutics Corp (SLXN:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.
Silexion Therapeutics Appoints Renowned Cancer Therapeutics Expert Prof ...
Cayman Islands, December 10, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for ...
Silexion Therapeutics Corp. Wt (SLXNW) Stock Price Today - WSJ
View the latest Silexion Therapeutics Corp. Wt (SLXNW) stock price, news, historical charts, analyst ratings and financial information from WSJ.
SLXN - Silexion Therapeutics Corp Sustainability - Morningstar
Review Silexion Therapeutics Corp (SLXN:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.
Similar Companies
Loading the latest forecasts...